Key Insights

Highlights

Success Rate

86% trial completion

Published Results

35 trials with published results (14%)

Research Maturity

151 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.8%

24 terminated out of 244 trials

Success Rate

86.3%

-0.2% vs benchmark

Late-Stage Pipeline

20%

49 trials in Phase 3/4

Results Transparency

23%

35 of 151 completed with results

Key Signals

35 with results86% success24 terminated

Data Visualizations

Phase Distribution

168Total
Not Applicable (91)
P 1 (16)
P 2 (12)
P 3 (28)
P 4 (21)

Trial Status

Completed151
Unknown34
Terminated24
Recruiting17
Withdrawn10
Active Not Recruiting5

Trial Success Rate

86.3%

Benchmark: 86.5%

Based on 151 completed trials

Clinical Trials (244)

Showing 20 of 20 trials
NCT07291700RecruitingPrimary

Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy

NCT06329583Not ApplicableCompletedPrimary

Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry

NCT04253392Active Not RecruitingPrimary

RETHINK REFLUX Registry

NCT05556824Phase 2Active Not RecruitingPrimary

Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

NCT04699591Not ApplicableRecruiting

Compassionate Use of Domperidone for Refractory Gastroparesis

NCT05697393Not ApplicableRecruitingPrimary

External UES Band (Shaker Pressure Band) and GERD

NCT04411823Not ApplicableRecruitingPrimary

Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction

NCT05976165Not ApplicableRecruitingPrimary

A Study of Breath Testing for Small Intestinal Bacterial Overgrowth

NCT04360252Not ApplicableActive Not RecruitingPrimary

Gracie Diet for Gastroesophageal Reflux Disease

NCT00431756Active Not Recruiting

Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus

NCT05874726Active Not Recruiting

Biological Sample Repository for Gastrointestinal Disorders

NCT06255886Phase 4RecruitingPrimary

Treatment of Gastroesophageal Reflux Disease in Infants

NCT06687603Not ApplicableRecruiting

Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms

NCT05695846Not ApplicableWithdrawnPrimary

Diagnostic Tests in Supra-Esophageal Gastroesophageal Reflux Disease (SE-GERD)

NCT03015610Phase 3Completed

Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma

NCT04960566Not ApplicableEnrolling By InvitationPrimary

Targeting Hypervigilance and Autonomic Arousal: the Psycho-physiologic Model of Gastroesophageal Reflux Disease (GERD)

NCT06534359Not ApplicableRecruiting

Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia

NCT05283447Not ApplicableCompletedPrimary

Manual Therapy and Gastroesophageal Reflux Disease in Patients With Hiatal Hernia

NCT06075082Not ApplicableCompletedPrimary

The Effect of the LEFT Smartwatch App as Sleep Positional Therapy for Nocturnal Gastroesophageal Reflux Symptoms.

NCT04720781Not ApplicableCompletedPrimary

The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole

Scroll to load more

Research Network

Activity Timeline